PHS
COR icon

PFM Health Sciences’s Cencora COR Stock Holding History

PFM Health Sciences’s Portfolio COR Stock Details COR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
+7,385
New +$2.13M 0.18% 89
2025
Q4 		– Sell
-80,493
Closed -$25.2M – 84
2025
Q3 		$25.2M Buy
80,493
+27,206
+51% +$8.01M 1.93% 14
2025
Q2 		$16M Buy
+53,287
New +$15.4M 1.36% 23
2020
Q2 		– Sell
-338,732
Closed -$30M – 83
2020
Q1 		$30M Buy
+338,732
New +$29.8M 2.46% 17

Other funds holding COR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PFM Health Sciences's COR Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Cencora (COR) in Q2 2026: 7,385 shares worth $2.09M. The stake represents 0.18% of the portfolio and ranks #89 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in COR as recently as Q3 2025.

PFM Health Sciences first reported a position in COR in Q1 2020 and has held it in 4 quarters since. The position peaked at $30M in Q1 2020. 1,345 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • PFM Health Sciences held 7,385 shares of Cencora worth $2.09M as of Q2 2026.
  • Cencora was a new PFM Health Sciences position in Q2 2026.
  • Cencora made up 0.18% of PFM Health Sciences's portfolio in Q2 2026, its #89 holding.
  • PFM Health Sciences first reported a position in Cencora in Q1 2020 and has held it in 4 quarters since.
  • PFM Health Sciences's Cencora position peaked at $30M in Q1 2020.
  • 1,345 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.